News
CAMBRIDGE, Mass., April 30, 2025--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) ("Amylyx" or the "Company") today announced that the first participant has been dosed in the pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback